Daily weight-loss pill: NZ weighs first bid
Daily weight-loss pill: NZ weighs first bid
Daily weight-loss pill: NZ weighs first bid
Key points
اہم نکات
मुख्य बातें
- New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports.
- The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week.
- The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
- New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports.
- The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week.
- The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
- New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports.
- The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week.
- The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports. The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week. The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports. The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week. The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
New Zealand's medicines regulator Medsafe is considering its first application for a daily oral GLP-1 weight-loss pill, 1News reports. The application is for oral Wegovy tablets, submitted under a reliance pathway that uses trusted overseas findings to shorten approval times, after Australia's regulator approved the first GLP-1 tablet this week. The daily pill would replace the weekly injection, and Medsafe says its first assessment usually takes about 75 working days, while doctors note there is still no long-term evidence on the tablet's safety and effectiveness.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।